Nicholas L. Place, serving as the Chief Banking Officer at Bridgewater Bancshares Inc. (NASDAQ:BWB), has formally disclosed a series of transactions involving the firm's common equity. The most significant activity occurred on June 5, 2026, when Place sold 4,688 shares of Bridgewater Bancshares common stock. The transaction was executed at a price of $19.275 per share, resulting in a total value of $90,361. These shares were held directly by the executive at the time of the sale.
The divestment takes place against a backdrop of positive market performance for Bridgewater Bancshares. As of the reporting period, BWB shares are trading near $19.43, a level that represents a strong ~30% return over the past year. Valuation metrics from InvestingPro analysis indicate that the stock trades at a P/E ratio of 11.13, accompanied by a notably low PEG ratio of 0.18. This combination suggests an attractive valuation relative to growth prospects, according to the platform's assessment. The analysis further identifies five additional ProTips for BWB investors, though specific details of these tips are not disclosed in the current report.
On June 8, Place engaged in a separate transaction involving the acquisition of options. He exercised options to acquire 12,500 shares of Bridgewater Bancshares common stock. The acquisition was made at an exercise price of $7.47 per share, totaling $93,375. These options were granted under the company’s 2017 Combined Incentive and Non-Statutory Stock Option Plan. The vesting schedule for these options was structured to become exercisable in 20% increments on the first five anniversaries of the grant date, which was October 1, 2017.
Following these transactions, Place's direct holdings in Bridgewater Bancshares common stock stand at 152,122 shares. Additionally, he holds an indirect position of 7,500 shares through a Spouse IRA. The executive also maintains a significant derivative portfolio. This includes 127,500 options to purchase common stock at an exercise price of $7.47, which are set to expire on September 30, 2027. Other outstanding options include 21,000 shares at an exercise price of $12.92, expiring on December 6, 2029, and 50,000 shares at an exercise price of $17.50, expiring on February 1, 2032. These options are exercisable in increments over several years from their respective grant dates.
The insider activity coincides with Bridgewater Bancshares' recent financial reporting. The company reported its Q1 2026 earnings, highlighting a strong revenue performance that surpassed market expectations. Revenue for the quarter reached $46.21 million, exceeding the anticipated $39.33 million by 17.49%. Earnings per share (EPS) were reported at $0.41, aligning precisely with analyst forecasts. These results underscore a robust financial performance for the company in the first quarter of 2026.
Market reaction to the earnings report appeared neutral, with no significant change in the stock’s premarket trading observed. The company did not announce any mergers or acquisitions during this period. Furthermore, analyst firms have not provided any recent upgrades or downgrades for Bridgewater Bancshares. These developments represent the latest updates from the company, reflecting a period of steady operational execution and stable analyst sentiment.